# Novel insights into short-term troponin remeasurement and long-term cardiac function and structure following fulminant myocarditis

**Authors:** Mengmeng Ji, Luying Jiang, Zixuan Zhang, Shupeng Jiang, Houjuan Zuo

PMC · DOI: 10.1016/j.ijcha.2025.101759 · 2025-07-28

## TL;DR

This study finds that delayed normalization of troponin levels in patients with fulminant myocarditis is linked to worse long-term heart function and structure.

## Contribution

The study identifies elevated troponin levels at 30 days post-discharge as a novel predictor of long-term cardiac deterioration in fulminant myocarditis patients.

## Key findings

- Patients with normal troponin levels at 30 days had better left ventricular function and structure over time.
- Elevated troponin at 30 days was strongly associated with higher incidence of secondary composite endpoints.
- Multivariable analysis confirmed troponin normalization as an independent predictor of cardiac outcomes.

## Abstract

Elevated serum high-sensitivity cardiac troponin (hs-cTn) levels are commonly observed in patients with fulminant myocarditis (FM) after the acute phase. This study aims to evaluate the relationship between elevated hs-cTnI levels at 30-day post-discharge and long-term cardiac structure and function.

This study is a retrospective cohort study that selected FM patients hospitalized at Tongji Hospital in Wuhan from April 2016 to December 2022. All patients underwent serial monitoring of hs-cTnI levels. Patients were stratified into two groups based on hs-cTnI levels at 30 days post-discharge: the normal hs-cTnI (N-cTnI) group and the high hs-cTnI (H-cTnI) group. Left ventricular (LV) function and structure were assessed using 2-dimensional volume and speckle tracking strain echocardiography. Measurements were obtained at admission, discharge, and 6 months, 12 months, and annually thereafter post-discharge.

Among 95 patients with analysable echocardiographic data (median age: 33 years; 42.11 % male), the N-cTnI group demonstrated significantly higher proportions of patients meeting cardiac function criteria during follow-up compared to the H-cTnI group: LV ejection fraction (LVEF) > 50 % (95 % vs. 72 %; P = 0.003), global longitudinal strain (GLS) > 16 % (68 % vs. 36 %; P = 0.002), and LV end-diastolic dimension < 5 cm (86 % vs. 65 %; P = 0.020). Given that the primary composite endpoint occurred in only 5 patients, statistical analyses focused on secondary composite endpoints. The incidence of secondary composite endpoints was significantly higher in the H-cTnI group than in the N-cTnI group (61.91 % vs. 16.98 %; P < 0.001). Multivariable Cox regression identified elevated hs-cTnI at 30 days post-discharge (HR: 5.365; 95 % CI: 1.876–15.344; P = 0.002) and LV-GLS at discharge (HR: 0.844; 95 % CI: 0.732–0.974; P = 0.021) as independent predictors of secondary composite endpoints.

Delayed normalization of hs-cTnI after 30 days post-discharge may predict long-term deterioration of cardiac function and structural remodeling in patients with FM.

## Full-text entities

- **Genes:** TNNI3 (troponin I3, cardiac type) [NCBI Gene 7137] {aka CMD1FF, CMD2A, CMH7, RCM1, TNNC1, cTnI}
- **Diseases:** FM (MESH:D009205), deterioration of cardiac function (MESH:D006331)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12329257/full.md

---
Source: https://tomesphere.com/paper/PMC12329257